These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 8445038

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Androgen-dependent prostatic tumors: biosynthesis and possible actions of LHRH.
    Limonta P, Moretti RM, Dondi D, Marelli MM, Motta M.
    J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):347-50. PubMed ID: 8043499
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop.
    Dondi D, Limonta P, Moretti RM, Marelli MM, Garattini E, Motta M.
    Cancer Res; 1994 Aug 01; 54(15):4091-5. PubMed ID: 8033142
    [Abstract] [Full Text] [Related]

  • 5. Growth of the androgen-dependent tumor of the prostate: role of androgens and of locally expressed growth modulatory factors.
    Limonta P, Dondi D, Marelli MM, Moretti RM, Negri-Cesi P, Motta M.
    J Steroid Biochem Mol Biol; 1995 Jun 01; 53(1-6):401-5. PubMed ID: 7626487
    [Abstract] [Full Text] [Related]

  • 6. Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP.
    Limonta P, Dondi D, Moretti RM, Maggi R, Motta M.
    J Clin Endocrinol Metab; 1992 Jul 01; 75(1):207-12. PubMed ID: 1320049
    [Abstract] [Full Text] [Related]

  • 7. The luteinizing hormone-releasing hormone receptor in human prostate cancer cells: messenger ribonucleic acid expression, molecular size, and signal transduction pathway.
    Limonta P, Moretti RM, Marelli MM, Dondi D, Parenti M, Motta M.
    Endocrinology; 1999 Nov 01; 140(11):5250-6. PubMed ID: 10537155
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of luteinizing hormone releasing hormone and its mRNA in human endometrial cancer cell lines.
    Irmer G, Bürger C, Ortmann O, Schulz KD, Emons G.
    J Clin Endocrinol Metab; 1994 Sep 01; 79(3):916-9. PubMed ID: 8077383
    [Abstract] [Full Text] [Related]

  • 11. Detection of mRNA expression of gonadotropin-releasing hormone and its receptor in normal and neoplastic rat prostates.
    Lau HL, Zhu XM, Leung PC, Chan LW, Chen GF, Chan PS, Yu KL, Chan FL.
    Int J Oncol; 2001 Dec 01; 19(6):1193-201. PubMed ID: 11713589
    [Abstract] [Full Text] [Related]

  • 12. Receptors for luteinizing hormone-releasing hormone (LHRH) in Dunning R3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75.
    Srkalovic G, Bokser L, Radulovic S, Korkut E, Schally AV.
    Endocrinology; 1990 Dec 01; 127(6):3052-60. PubMed ID: 2174343
    [Abstract] [Full Text] [Related]

  • 13. Expression of gonadotropin-releasing hormone and prothymosin-alpha messenger ribonucleic acid in the ovary.
    Oikawa M, Dargan C, Ny T, Hsueh AJ.
    Endocrinology; 1990 Nov 01; 127(5):2350-6. PubMed ID: 2226321
    [Abstract] [Full Text] [Related]

  • 14. Growth factors in steroid-responsive prostatic tumor cells.
    Dondi D, Moretti RM, Marelli MM, Motta M, Limonta P.
    Steroids; 1996 Apr 01; 61(4):222-5. PubMed ID: 8733005
    [Abstract] [Full Text] [Related]

  • 15. Neural and glial-mediated effects of growth factors acting via tyrosine kinase receptors on luteinizing hormone-releasing hormone neurons.
    Voigt P, Ma YJ, Gonzalez D, Fahrenbach WH, Wetsel WC, Berg-von der Emde K, Hill DF, Taylor KG, Costa ME, Seidah NG, Ojeda SR.
    Endocrinology; 1996 Jun 01; 137(6):2593-605. PubMed ID: 8641214
    [Abstract] [Full Text] [Related]

  • 16. Luteinizing hormone-releasing hormone (LHRH) in rat prostate: characterization of LHRH peptide, messenger ribonucleic acid expression, and molecular processing of LHRH in intact and castrated male rats.
    Azad N, Uddin S, La Paglia N, Kirsteins L, Emanuele NV, Lawrence AM, Kelley MR.
    Endocrinology; 1993 Sep 01; 133(3):1252-7. PubMed ID: 8365367
    [Abstract] [Full Text] [Related]

  • 17. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.
    Gründker C, Völker P, Emons G.
    Endocrinology; 2001 Jun 01; 142(6):2369-80. PubMed ID: 11356684
    [Abstract] [Full Text] [Related]

  • 18. Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats.
    Pinski J, Lamharzi N, Halmos G, Groot K, Jungwirth A, Vadillo-Buenfil M, Kakar SS, Schally AV.
    Endocrinology; 1996 Aug 01; 137(8):3430-6. PubMed ID: 8754771
    [Abstract] [Full Text] [Related]

  • 19. Role of growth factors, steroid and peptide hormones in the regulation of human prostatic tumor growth.
    Motta M, Dondi D, Moretti RM, Montagnani Marelli M, Pimpinelli F, Maggi R, Limonta P.
    J Steroid Biochem Mol Biol; 1996 Jan 01; 56(1-6 Spec No):107-11. PubMed ID: 8603030
    [Abstract] [Full Text] [Related]

  • 20. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.
    Gründker C, Völker P, Schulz KD, Emons G.
    Gynecol Oncol; 2000 Aug 01; 78(2):194-202. PubMed ID: 10926802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.